HF
ATEX icon

HRT Financial’s Anterix ATEX Stock Holding History

HRT Financial’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Sell
30,673
-144,252
-82% -$8.47M 0.01% 1431
2026
Q1 		$6.68M Buy
174,925
+131,835
+306% +$4.17M 0.02% 828
2025
Q4 		$940K Sell
43,090
-19,043
-31% -$395K ﹤0.01% 1755
2025
Q3 		$1.33M Buy
+62,133
New +$1.39M ﹤0.01% 1370
2025
Q2 		– Sell
-20,716
Closed -$758K – 2582
2025
Q1 		$758K Buy
+20,716
New +$713K ﹤0.01% 1261
2024
Q4 		– Sell
-42,933
Closed -$1.62M – 2417
2024
Q3 		$1.62M Buy
42,933
+8,634
+25% +$333K 0.01% 974
2024
Q2 		$1.36M Buy
+34,299
New +$1.11M 0.01% 879
2023
Q4 		– Sell
-39,516
Closed -$1.24M – 2297
2023
Q3 		$1.24M Buy
+39,516
New +$1.24M 0.01% 858
2021
Q2 		– Sell
-4,967
Closed -$234K – 2822
2021
Q1 		$234K Buy
+4,967
New +$204K ﹤0.01% 2234
2020
Q4 		– Sell
-17,916
Closed -$586K – 1825
2020
Q3 		$586K Buy
+17,916
New +$758K 0.02% 805

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

HRT Financial's ATEX Position: Q2 2026 in Review

HRT Financial reduced its Anterix (ATEX) stake by 82% in Q2 2026, selling an estimated $8.47M and leaving 30,673 shares worth $3.16M. The position accounts for 0.01% of the portfolio, ranked #1431.

HRT Financial first reported a position in ATEX in Q3 2020 and has held it in 10 quarters since. The position peaked at $6.68M in Q1 2026. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • HRT Financial held 30,673 shares of Anterix worth $3.16M as of Q2 2026.
  • HRT Financial sold 144,252 Anterix shares in Q2 2026, an estimated $8.47M.
  • Anterix made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1431 holding.
  • HRT Financial first reported a position in Anterix in Q3 2020 and has held it in 10 quarters since.
  • HRT Financial's Anterix position peaked at $6.68M in Q1 2026.
  • 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.